About
Our focus includes glycosidic triterpene saponins, mutable collagenous peptides and polysaccharides, with documented potential to support epithelial function, modulate inflammatory responses, and potential to act as disease recovery adjuncts.
Founded on principal experience in oncology drug development and supported by a dedicated marine research, development and manufacturing facility commissioned in 2022, Sea Hero Bioscience applies robust preclinical and translational frameworks to its work. We leverage clinical and technical collaborations with leading research organisations in New Zealand and internationally to identify, refine, and validate marine and terrestrial co-factors that are under-represented in pharmaceutical innovation pipelines.
Our Mission is to enable people to access high quality bioactive marine compounds and products to support their health.
At Sea Hero Bioscience, we recognise that conventional product pipelines often overlook naturally occurring compounds with significant potential, particularly those from wild marine sources. Many of these compounds, including triterpene saponins, mutable peptides, sulphated polysaccharides and proteoglycans, have been traditionally consumed for centuries but remain poorly standardised, under-researched, or ignored in modern biotechnology and pharmaceutical development.
Sea Hero Bioscience focuses its research on three interrelated clinical domains:
1.
Marine-derived topical and nutritional skincare technologies
2.
Biologically active compounds and dietary support to support gut and brain health.
3.
Biologically active compounds and dietary support to support immunity.
*Our research integrates proprietary extraction and formulation processes with clinical partnerships to translate marine-derived and botanical actives into reliable, standardised products.
Our product formulations address critical gaps in epithelial and immune support, translating marine bioactives into therapeutic applications for skin, gut, and systemic recovery.
Learn More